Insider Trading activities at Pasithea Therapeutics Corp. (KTTA)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pasithea Therapeutics Corp. (KTTA) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pasithea Therapeutics Corp.. Table 2 shows the detailed insider transactions. This company's CIK number is 1841330.

Total stock buying since 2022: $230,877.
Total stock sales since 2022: $792.
Total stock option exercises since 2022: $0.


4 insiders reported insider trading activities at Pasithea Therapeutics Corp. (KTTA):
Insider trading activities of Camac Partners, Llc
Insider trading activities of Steinman Lawrence
Insider trading activities of Elderhill Corp
Insider trading activities of Marques Tiago

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Pasithea Therapeutics Corp. (KTTA).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 960 $792 0 $0
2023 30,000 $12,930 0 $0 0 $0
2022 181,601 $217,947 0 $0 0 $0

Table 2. Monthly summary of insider trading at Pasithea Therapeutics Corp. (KTTA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-05 0 $0 960 $792 0 $0
2023-06 30,000 $12,930 0 $0 0 $0
2022-10 3,000 $3,330 0 $0 0 $0
2022-08 178,601 $214,617 0 $0 0 $0

Table 3. Detailed insider trading at Pasithea Therapeutics Corp. (KTTA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-05-12 Marques Tiago (Chief Executive Officer) Sale 960 .82 792
2023-06-02 Steinman Lawrence Buy 30,000 .43 12,930
2022-10-17 Elderhill Corp (Other) Buy 2,000 1.11 2,220
2022-08-30 Camac Partners, Llc (Other) Buy 17,828 1.15 20,448
2022-08-29 Camac Partners, Llc (Other) Buy 5,000 1.17 5,840
2022-08-17 Camac Partners, Llc Buy 155,773 1.21 188,329

Insider trading activities including stock purchases, stock sales, and option exercises of KTTA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pasithea Therapeutics Corp. (symbol KTTA, CIK number 1841330) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.